CLLAN webinar on CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs – video recording
On 6 December 2022, CLLAN (CLL Advocates Network) hosted a webinar on “CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs”.
This educational session discussed advances in how relapsed/refractory CLL patients and those who fail a treatment are treated today. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs?
During this session we explored:
- Fixed term and continuous treatments
- Solutions in the multiple-relapsed-refractory group
- Overcoming challenges for the clinician and the patient
- New technologies
- Treatment sequencing
We were joined by:
Nick York – CLL Patient, Patient Advocacy Healthcare Liaison Officer, Leukaemia Care (UK)
Dr Talha Munir – Consultant Haematologist, Leeds Teaching Hospitals NHS Trust (UK)
Dr Brian Koffman – CLL patient & family physician, Co-Founder, Executive VP and Chief Medical Officer, CLL Society (US)
Lelia Duley – CLL Patient, Emeritus Professor of Research, Associate Trustee, CLL Support (UK)
A big thank you to our panellists for their excellent presentation, insight and for sharing their wealth of experience.
This webinar was organised by CLL Advocates Network.
We would like to thank the following for their support: